$康方生物(0992_老虎社区_美港股上老虎

$康方生物(09926)$ 康方生物宣布其三特异性抗体新药AK150获得NMPA临床试验默示许可，用于治疗晚期恶性实体瘤

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":543299565081264,"tweetId":"543299565081264","gmtCreate":1773667070670,"gmtModify":1773667072497,"author":{"id":3549961257478316,"idStr":"3549961257478316","authorId":3549961257478316,"authorIdStr":"3549961257478316","name":"红色遥控器","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":59,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/09926\">$康方生物(09926)$&nbsp;</a> 康方生物宣布其三特异性抗体新药AK150获得NMPA临床试验默示许可，用于治疗晚期恶性实体瘤</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/09926\">$康方生物(09926)$&nbsp;</a> 康方生物宣布其三特异性抗体新药AK150获得NMPA临床试验默示许可，用于治疗晚期恶性实体瘤</p></body></html>","text":"$康方生物(09926)$ 康方生物宣布其三特异性抗体新药AK150获得NMPA临床试验默示许可，用于治疗晚期恶性实体瘤","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/543299565081264","repostId":0,"isVote":1,"tweetType":1,"viewCount":571,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["09926"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":99,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}